Seattle, WA, United States of America

Mary Prieve

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Deverra Therapeutics Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary Prieve. Retrieved from https://idiyas.com/inventor/mary-prieve

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mary Prieve: Innovator in Immunotherapy

Introduction

Mary Prieve is a notable inventor based in Seattle, WA (US). She has made significant contributions to the field of immunotherapy, particularly through her innovative research and development efforts.

Latest Patents

Mary Prieve holds a patent for "NK Cell Compositions and Preparations for Immunotherapy and Methods for Their Production." This patent highlights her work in creating effective treatments that harness the power of natural killer cells to combat diseases.

Career Highlights

Mary is currently associated with Deverra Therapeutics Inc., where she continues to advance her research in immunotherapy. Her dedication to innovation has positioned her as a key figure in her field.

Collaborations

Throughout her career, Mary has collaborated with esteemed colleagues, including Colleen Delaney and Carrie Stoltzman. These partnerships have further enriched her work and contributed to the success of her projects.

Conclusion

Mary Prieve's contributions to immunotherapy through her patent and collaborative efforts underscore her importance as an inventor in the medical field. Her work continues to inspire advancements in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…